Celcuity Announces Pricing of Underwritten Common Stock Offering
May 30, 2024 07:36 ET
|
Celcuity Inc.
MINNEAPOLIS, May 30, 2024 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the...
AGF Investments Announces Uncapping of AGF Fixed Income Plus Class Series MF and Q
May 30, 2024 07:25 ET
|
AGF Management Ltd.
TORONTO, May 30, 2024 (GLOBE NEWSWIRE) -- AGF Investments Inc. (AGF Investments) (TSX:AGF.B) today announced the uncapping of AGF Fixed Income Plus Class MF Series and Q Series to new investors,...
Placements AGF annonce la réouverture de la Catégorie Revenu fixe Plus AGF, série OPC et série Q
May 30, 2024 07:25 ET
|
La Société de Gestion AGF Limitée
TORONTO, 30 mai 2024 (GLOBE NEWSWIRE) -- Placements AGF Inc. (« Placements AGF ») (TSX:AGF.B) a annoncé aujourd’hui que les séries OPC et Q de la Catégorie Revenu fixe Plus AGF seront rouvertes aux...
Elevar Therapeutics Reports Landmark Median Overall Survival of 23.8 Months in First-Line Treatment for Unresectable Hepatocellular Carcinoma
May 30, 2024 07:00 ET
|
Elevar Therapeutics
Phase 3 CARES-310 study found combination of camrelizumab and rivoceranib continued to show sustained long-term survival compared with sorafenib as a first-line treatment for uHCCFinal analysis...
Cibus’ White Mold (Sclerotinia) Resistance Trait Program Confirms Important Milestone for Next Generation Gene Edits in Canola
May 30, 2024 07:00 ET
|
Cibus US LLC
Cibus has successfully made the edits in Canola associated with the Company’s 3rd mode of action for its White Mold (Sclerotinia) trait These next generation edits are now confirmed in plants and...
Village Farms International Boosts Ownership in Fast-Growing Rose LifeScience
May 30, 2024 07:00 ET
|
Village Farms International, Inc.
VANCOUVER, British Columbia and ORLANDO, Fla., May 30, 2024 (GLOBE NEWSWIRE) -- Village Farms International, Inc. (“Village Farms” or “the Company”) (NASDAQ: VFF) today announces it has increased...
LAVA Therapeutics to Participate in the Jefferies Global Healthcare Conference
May 30, 2024 07:00 ET
|
LAVA Therapeutics N.V.
UTRECHT, The Netherlands and PHILADELPHIA, May 30, 2024 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (NASDAQ: LVTX, “LAVA,” or “Company”), a clinical-stage immuno-oncology company focused on...
Amplify ETFs Declares May Income Distributions for its ETFs
May 30, 2024 07:00 ET
|
Amplify ETFs
Amplify ETFs announces May income distributions for its ETFs.
Celcuity Inc. Announces Plan to Initiate a Phase 3 Clinical Trial for Gedatolisib as First-Line Treatment for HR+/HER2- Advanced Breast Cancer and Secures Approximately $62 Million Debt Financing
May 30, 2024 07:00 ET
|
Celcuity Inc.
The Phase 3 clinical trial will evaluate gedatolisib plus a CDK4/6 inhibitor and fulvestrant as first-line treatment for patients with HR+/HER2- advanced breast cancer who are endocrine therapy...
Virtu Financial, Inc. Announces Investor Meetings for Potential Opportunistic Offering of Senior Secured First Lien Notes
May 30, 2024 07:00 ET
|
Virtu Financial, LLC
NEW YORK, May 30, 2024 (GLOBE NEWSWIRE) -- Virtu Financial Inc. (Nasdaq: VIRT) (the “Company”) announced today that it intends to hold one or more meetings with potential investors with respect to a...